Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Hepatic Lipid Content in Healthy Humans
NCT02164032Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in non-alcoholic fatty liver disease (NAFLD), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
regular human insulin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02164032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164032.